Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Lumexa Imaging Holdings, Inc. (LMRI) Market Cap & Valuation Ratios

Lumexa Imaging Holdings, Inc. (LMRI) has a market cap of $1.1B and a price-to-sales ratio of 4.2, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · read by EquiReason

LMRILumexa Imaging Holdings, Inc.Follow LMRI — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
1.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Peers

diagnostics & research · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
LMRI1.1—————9%—
CDNA3.633.47.026.21.0%+34%24%67%
NEO2.1—3.1—-0.3%+11%-9%-7%
PSNL1.7—21.2—-6.0%-13%-164%-82%
WGS1.7—3.6—-4.5%+25%-20%-35%
OPK1.2—2.130.5-11.0%-11%-8%-4%
CSTL1.0—2.1—-0.0%+3%-9%-8%
MYGN0.6—0.7—-1.3%-3%-12%-29%
FLGT0.6—0.9——+7%-38%-12%
YDES0.4—280.8—-2.5%+17%—-362%
TKNO0.3—7.8—-2.1%+12%-36%-20%
Median of these 1033.43.328.3-2.1%+9%-12%-16%

.

Growth vs. price

each dot a company · hover or tap for values

Lumexa Imaging Holdings, Inc. — questions

What is Lumexa Imaging Holdings, Inc.'s market cap?
$1.1B.
What is Lumexa Imaging Holdings, Inc.'s price-to-sales ratio?
4.2.

Every figure on this page comes from Lumexa Imaging Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.